Literature DB >> 24678116

Linezolid compared with vancomycin for the prevention of methicillin-resistant Staphylococcus aureus or Staphylococcus epidermidis vascular graft infection in rats: A randomized, controlled, experimental study.

Suzan Sacar1, Mustafa Sacar2, Ilknur Kaleli3, Semra Toprak1, Nural Cevahir3, Zafer Teke4, Ali Asan1, Barbaros Sahin5, Ahmet Baltalarli2, Huseyin Turgut1.   

Abstract

BACKGROUND: Graft infections are severe complications of vascular surgery that may result in amputation or mortality. Staphylococci are the most frequent cause of vascular graft infections.
OBJECTIVE: In this study we assessed the prophylactic efficacy of linezolid in comparison with vancomycin in preventing prosthetic vascular graft infection due to methicillin-resistant Staphylococcus aureus (MRSA) or methicillin-resistant Staphylococcus epidermidis (MRSE).
METHODS: This randomized, controlled, experimental study using healthy adult (aged >5 months) male Wistar rats was conducted in the research laboratory of the Pamukkale University, Denizli, Turkey. The study consisted of an uncontaminated control group and 3 groups for both staphylococcal strains: a contaminated group that did not receive any antibiotic prophylaxis; a contaminated group that received preoperative intraperitoneal (IP) prophylaxis with vancomycin; and a contaminated group that received preoperative IP prophylaxis with linezolid. All rats received a vascular Dacron graft placed inside a subcutaneous pocket created on the right side of the median line. Sterile saline solution (1 mL), to which MRSA or MRSE at a concentration of 2 × 10(7) colony-forming units per milliliter had been added, was inoculated onto the graft surface using a tuberculin syringe to fill the pocket. The grafts were explanted 7 days after implantation and assessed by quantitative culture.
RESULTS: Seventy rats (mean [SD]weight, 323.7 [17.9]g; mean [SD]age, 5.98 [0.64] months) were evenly divided between the 7 groups. Statistical analysis of the quantitative graft culture suggested that both vancomycin and linezolid were effective in significantly inhibiting bacterial growth when compared with the untreated contaminated groups (all, P < 0.001). However, a statistically significant difference was not observed between the bacteria count in the vancomycin and linezolid prophylaxis groups. When a comparison was made between the bacterial growth in the contaminated control groups, MRSA had significantly greater affinity to the Dacron prostheses than MRSE (all, P < 0.001).
CONCLUSION: Our study found that linezolid was as effective as vancomycin in suppressing colony counts in MRSA- or MRSE-infected vascular Dacron grafts in rats.

Entities:  

Keywords:  linezolid; vancomycin; vascular graft infection

Year:  2007        PMID: 24678116      PMCID: PMC3965976          DOI: 10.1016/j.curtheres.2007.02.001

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN: 0011-393X


  28 in total

Review 1.  Glycopeptide-resistant Staphylococcus aureus.

Authors:  Alan P Johnson; Neil Woodford
Journal:  J Antimicrob Chemother       Date:  2002-11       Impact factor: 5.790

Review 2.  Linezolid.

Authors:  D Clemett; A Markham
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

3.  Susceptibility of a variety of clinical isolates to linezolid: a European inter-country comparison.

Authors:  C G Gemmell
Journal:  J Antimicrob Chemother       Date:  2001-07       Impact factor: 5.790

Review 4.  Oxazolidinone antibiotics.

Authors:  D J Diekema; R N Jones
Journal:  Lancet       Date:  2001-12-08       Impact factor: 79.321

5.  In vitro activities of the oxazolidinone antibiotics U-100592 and U-100766 against Staphylococcus aureus and coagulase-negative Staphylococcus species.

Authors:  J H Jorgensen; M L McElmeel; C W Trippy
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

6.  Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.

Authors:  T L Smith; M L Pearson; K R Wilcox; C Cruz; M V Lancaster; B Robinson-Dunn; F C Tenover; M J Zervos; J D Band; E White; W R Jarvis
Journal:  N Engl J Med       Date:  1999-02-18       Impact factor: 91.245

Review 7.  Linezolid in vitro: mechanism and antibacterial spectrum.

Authors:  David M Livermore
Journal:  J Antimicrob Chemother       Date:  2003-05       Impact factor: 5.790

8.  The natural history of bacterial biofilm graft infection.

Authors:  T M Bergamini; R A Corpus; K R Brittian; J C Peyton; W G Cheadle
Journal:  J Surg Res       Date:  1994-05       Impact factor: 2.192

9.  Mortality and limb loss with infected infrainguinal bypass grafts.

Authors:  M J Kikta; S F Goodson; R A Bishara; J P Meyer; J J Schuler; D P Flanigan
Journal:  J Vasc Surg       Date:  1987-04       Impact factor: 4.268

10.  Systemic and local antibiotic prophylaxis in the prevention of Staphylococcus epidermidis graft infection.

Authors:  Huseyin Turgut; Suzan Sacar; Ilknur Kaleli; Mustafa Sacar; Ibrahim Goksin; Semra Toprak; Ali Asan; Nural Cevahir; Koray Tekin; Ahmet Baltalarli
Journal:  BMC Infect Dis       Date:  2005-10-21       Impact factor: 3.090

View more
  1 in total

1.  Incidence and susceptibility pattern of methicillin resistant coagulase-negative staphylococci isolated from a tertiary care hospital of pakistan.

Authors:  Muhammad Usman Shah; Muhammad Farhan Akram; Javaid Usman; Fatima Kaleem
Journal:  Jundishapur J Microbiol       Date:  2014-01-01       Impact factor: 0.747

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.